Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT
ANNALS OF THE RHEUMATIC DISEASES（2020）
摘要
An amendment to this paper has been published and can be accessed via the original article.
更多查看译文
关键词
Rheumatoid arthritis,Patient-reported outcomes,JAK inhibitor,Health-related quality of life,Treatment outcomes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要